LPA1/3 signaling mediates tumor lymphangiogenesis through promoting CRT expression in prostate cancer-Reference-Cited by-同舟云学术

LPA1/3 signaling mediates tumor lymphangiogenesis through promoting CRT expression in prostate cancer

Published:2018-10 Issue:10 Volume:1863 Page:1305-1315
ISSN:1388-1981
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids

Author:

Lin Yueh-Chien,Chen Chien-Chin,Chen Wei-Min,Lu Kuan-Ying,Shen Tang-Long,Jou Yeong-Chin,Shen Cheng-Huang,Ohbayashi Norihiko,Kanaho Yasunori,Huang Yuan-Li,Lee Hsinyu

Funder

National Health Research Institute

Ministry of Science and Technology

Chia-Yi Christian Hospital

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference65 articles.

1. International variation in prostate cancer incidence and mortality rates;Center;Eur. Urol.,2012

2. The metastatic cascade in prostate cancer;Arya;Surg. Oncol.,2006

3. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases;Joukov;EMBO J.,1996